KRYS
Krystal Biotech, Inc.
NASDAQ · Healthcare · Biotechnology · US
$358.24
−3.56%Forward multiples
Based on analyst estimates
- P/E forward
- 42.35x
- P/E 2026E
- 46.89x
- P/E 2027E
- 37.85x
- P/E 2028E
- 23.88x
- P/S forward
- 18.62x
Trailing multiples
Trailing twelve months
- P/E TTM
- 43.32x
- PEG TTM
- 18.99x
- Price / book
- 7.80x
- Price / sales
- 24.07x
- Price / cash flow
- 38.94x
Enterprise value
- Enterprise value
- $9.8B
- EV / sales
- 22.17x
- EV / EBITDA
- 44.71x
- EV / EBIT
- 49.35x
- Market cap
- $10.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026